Back to Search
Start Over
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors
- Source :
- Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 19(11)
- Publication Year :
- 2021
-
Abstract
- Given the increasing use of novel targeted therapies, dermatologists are constantly confronted with novel cutaneous side effects of these agents. A rapid diagnosis and appropriate management of these side effects are crucial to prevent impairment of the patients' quality of life and interruptions of essential cancer treatments. Immune checkpoint and EGFR inhibitors are frequently used targeted therapies for various malignancies and are associated with a distinct spectrum of cutaneous adverse events. Exanthematous drug eruptions represent a particular diagnostic challenge in these patients. Immune checkpoint inhibitors can elicit a plethora of immune-related exanthemas, most commonly maculopapular, lichenoid, and psoriasiform eruptions. Additionally, autoimmune bullous dermatoses and exanthemas associated with connective tissue diseases may arise. In cases of severe, atypical or therapy-resistant presentations an extensive dermatological investigation including a skin biopsy is recommended. Topical and systemic steroids are the mainstay of treatment. Papulopustular eruptions represent the major cutaneous adverse effect of EGFR inhibitor therapy, occurring in up to 90 % of patients within the first two weeks of therapy, depending on the agent. Besides topical antibiotics and steroids, oral tetracyclines are the first choice in systemic treatment and can also be used as prophylaxis.
- Subjects :
- Drug
medicine.medical_specialty
medicine.diagnostic_test
business.industry
media_common.quotation_subject
Immune checkpoint inhibitors
Cancer
Dermatology
medicine.disease
Immune checkpoint
ErbB Receptors
Papulopustular
Neoplasms
Skin biopsy
medicine
Quality of Life
Humans
Drug Eruptions
Immunotherapy
business
Adverse effect
media_common
EGFR inhibitors
Subjects
Details
- ISSN :
- 16100387
- Volume :
- 19
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
- Accession number :
- edsair.doi.dedup.....7a4f2afa35fec8418133f1c62e4e7dff